Atea Pharmaceuticals
(NASDAQ:AVIR)
$7.31
0.25[3.54%]
At close: Jun 29
$7.31
00
After Hours: 4:08PM EDT
15 minutes delayed
Day High/Low6.92 - 7.34
52 Week High/Low5.31 - 46.91
Open / Close7.01 / 7.31
Float / Outstanding63.2M / 83.3M
Vol / Avg.504.9K / 739K
Mkt Cap608.6M
P/E13.58
50d Avg. Price6.84
Div / Yield-
Payout Ratio-
EPS-0.51
Total Float63.2M

Atea Pharmaceuticals (NASDAQ:AVIR), Quotes and News Summary

Atea Pharmaceuticals (NASDAQ: AVIR)

Day High/Low6.92 - 7.34
52 Week High/Low5.31 - 46.91
Open / Close7.01 / 7.31
Float / Outstanding63.2M / 83.3M
Vol / Avg.504.9K / 739K
Mkt Cap608.6M
P/E13.58
50d Avg. Price6.84
Div / Yield-
Payout Ratio-
EPS-0.51
Total Float63.2M
Sector: Health Care.Industry: Pharmaceuticals
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing therapies to address the unmet medical needs of patients with severe viral diseases. Its programs are focused on the development of orally- administered direct acting antivirals for the treatment of patients with COVID-19 in the hospital and community settings, the treatment of patients with chronic hepatitis C infection, the treatment of patients with dengue, and the treatment of high-risk patients with severe respiratory syncytial virus infection. The company's medicinal chemistry, virology, and pharmacology expertise, bolstered by its collective experience in drug development, enables it to pioneer new advancements in antiviral science.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.580-0.510 0.0700
REV3.330M0-3.330M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Atea Pharmaceuticals Questions & Answers

Q
How do I buy Atea Pharmaceuticals (AVIR) stock?
A

You can purchase shares of Atea Pharmaceuticals (NASDAQ: AVIR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Atea Pharmaceuticals's (AVIR) competitors?
Q
What is the target price for Atea Pharmaceuticals (AVIR) stock?
A

The latest price target for Atea Pharmaceuticals (NASDAQ: AVIR) was reported by JP Morgan on Wednesday, March 2, 2022. The analyst firm set a price target for 8.00 expecting AVIR to rise to within 12 months (a possible 9.44% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Atea Pharmaceuticals (AVIR)?
A

The stock price for Atea Pharmaceuticals (NASDAQ: AVIR) is $7.31 last updated Today at June 29, 2022, 8:00 PM UTC.

Q
Does Atea Pharmaceuticals (AVIR) pay a dividend?
A

There are no upcoming dividends for Atea Pharmaceuticals.

Q
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
A

Atea Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Atea Pharmaceuticals (AVIR) going to split?
A

There is no upcoming split for Atea Pharmaceuticals.

Q
What sector and industry does Atea Pharmaceuticals (AVIR) operate in?
A

Atea Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.